ARUK 2021 | Hopes and challenges in AD research

Dervis Salih, PhD, University College London, London, UK, expresses challenges that researchers have within Alzheimer’s disease (AD) treatment, as well as potential developments within the field. Current hurdles in AD research include not being able to predict AD in patients at an earlier stage, which would be beneficial, as earlier interventions may lead to improved patient outcomes. Dr. Salih also mentions that with increased genomic and proteomic data, new biomarkers that can identify disease risk can be found, which can lead to a diagnostic blood test. This interview took place during the Alzheimer’s Research UK (ARUK) Conference 2021.